Your browser doesn't support javascript.
loading
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.
Norrby, Maria; Vesikari, Timo; Lindqvist, Lars; Maeurer, Markus; Ahmed, Raija; Mahdavifar, Shahnaz; Bennett, Sean; McClain, J Bruce; Shepherd, Barbara M; Li, Daner; Hokey, David A; Kromann, Ingrid; Hoff, Søren T; Andersen, Peter; de Visser, Adriëtte W; Joosten, Simone A; Ottenhoff, Tom H M; Andersson, Jan; Brighenti, Susanna.
  • Norrby M; Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Vesikari T; Vaccine Research Center, University of Tampere, Tampere, Finland.
  • Lindqvist L; Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Maeurer M; TIM, Department of Laboratory Medicine and CAST, Karolinska Institutet, Stockholm, Sweden.
  • Ahmed R; TIM, Department of Laboratory Medicine and CAST, Karolinska Institutet, Stockholm, Sweden.
  • Mahdavifar S; TIM, Department of Laboratory Medicine and CAST, Karolinska Institutet, Stockholm, Sweden.
  • Bennett S; Aeras, Rockville, MD, USA.
  • McClain JB; Aeras, Rockville, MD, USA.
  • Shepherd BM; Aeras, Rockville, MD, USA.
  • Li D; Aeras, Rockville, MD, USA.
  • Hokey DA; Aeras, Rockville, MD, USA.
  • Kromann I; Statens Serum Institut, Copenhagen, Denmark.
  • Hoff ST; Statens Serum Institut, Copenhagen, Denmark.
  • Andersen P; Statens Serum Institut, Copenhagen, Denmark.
  • de Visser AW; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Joosten SA; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Andersson J; Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Center for Infectious Medicine (CIM), Karolinska Institutet, Stockholm, Sweden.
  • Brighenti S; Center for Infectious Medicine (CIM), Karolinska Institutet, Stockholm, Sweden. Electronic address: susanna.brighenti@ki.se.
Vaccine ; 35(12): 1652-1661, 2017 03 14.
Article en En | MEDLINE | ID: mdl-28216183
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Vacunas contra la Tuberculosis Tipo de estudio: Clinical_trials Límite: Adult / Humans País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Vacunas contra la Tuberculosis Tipo de estudio: Clinical_trials Límite: Adult / Humans País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article